NCT03793400View on ClinicalTrials.gov

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

March 13, 2018

Primary Completion Date

April 13, 2018

Study Completion Date

December 28, 2018

Conditions
Choroidal NeovascularizationPunctate Inner Choroidopathy
Interventions
DRUG

Bevacizumab Injection

Anti-vascular endothelial growth factor (VEGF)

Trial Locations (1)

Unknown

Changhua Christian Hospital, Changhua

All Listed Sponsors
lead

Changhua Christian Hospital

OTHER

NCT03793400 - Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor | Biotech Hunter | Biotech Hunter